
AbbVie Inc (ABBV)
US$ 186.110.26%
Price Chart
Key Statistics
Market Cap
$ 344.84B
P/E Ratio
92.52
Revenue (TTM)
$ 58.33B
Volume
11.39M
52W High
$ 214.80
52W Low
$ 159.42
Dividend Yield
1.69%
Beta
0.48
Technicals
50-Day MA
188.1756
200-Day MA
187.8588
52 Week High
214.8025
52 Week Low
159.4168
About ABBV
AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacture, commercialization, and sale of medicines and therapies worldwide.
Employees
55000
Headquarters
North Chicago, IL
CEO
Mr. Robert A. Michael CPA
Latest News
Why AbbVie (ABBV) Stock Is Up Today - Yahoo Finance
Yesterday • Google News
AbbVie stock gains as company posts Q2 beat (ABBV:NYSE) - Seeking Alpha
2 days ago • Google News
Environment, Social and Governance (ESG) Risk Ratings
Total ESG Risk Score
34.86
Percentile: 65.78
Environmental Risk Score
4.96
Percentile: 7
Social Risk Score
22.65
Percentile: 7
Governance Risk Score
16.25
Percentile: 7
Controversy Level
ESG data provided by Sustainalytics, Inc.
ABBV
Category Average
3Significant Controversy Level
NoneSevere
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg